Two compounds target drug-resistant brain cancer cells in laboratory tests
Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths. The current standard of care involves the use of temozolomide (TMZ), a che
<p>Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths. The current standard of care involves the use of temozolomide (TMZ), a che</p>